Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 186

1.

Alzheimer's genetic risk is reduced in primary age-related tauopathy: a potential model of resistance?

McMillan CT, Lee EB, Jefferson-George K, Naj A, Van Deerlin VM, Trojanowski JQ, Wolk DA.

Ann Clin Transl Neurol. 2018 Jun 19;5(8):927-934. doi: 10.1002/acn3.581. eCollection 2018 Aug.

2.

Inherited and Acquired Decrease in Complement Receptor 1 (CR1) Density on Red Blood Cells Associated with High Levels of Soluble CR1 in Alzheimer's Disease.

Mahmoudi R, Feldman S, Kisserli A, Duret V, Tabary T, Bertholon LA, Badr S, Nonnonhou V, Cesar A, Neuraz A, Novella JL, Cohen JHM.

Int J Mol Sci. 2018 Jul 25;19(8). pii: E2175. doi: 10.3390/ijms19082175.

3.

PICALM Gene Methylation in Blood of Alzheimer's Disease Patients Is Associated with Cognitive Decline.

Mercorio R, Pergoli L, Galimberti D, Favero C, Carugno M, Dalla Valle E, Barretta F, Cortini F, Scarpini E, Valentina VB, Pesatori AC.

J Alzheimers Dis. 2018;65(1):283-292. doi: 10.3233/JAD-180242.

PMID:
30040717
4.

Peripheral complement interactions with amyloid β peptide in Alzheimer's disease: Polymorphisms, structure, and function of complement receptor 1.

Johansson JU, Brubaker WD, Javitz H, Bergen AW, Nishita D, Trigunaite A, Crane A, Ceballos J, Mastroeni D, Tenner AJ, Sabbagh M, Rogers J.

Alzheimers Dement. 2018 May 21. pii: S1552-5260(18)30125-0. doi: 10.1016/j.jalz.2018.04.003. [Epub ahead of print]

PMID:
29792870
5.

Alzheimer's disease susceptibility genes modify the risk of Parkinson disease and Parkinson's disease-associated cognitive impairment.

Fang L, Tang BS, Fan K, Wan CM, Yan XX, Guo JF.

Neurosci Lett. 2018 Jun 11;677:55-59. doi: 10.1016/j.neulet.2018.04.042. Epub 2018 Apr 24.

PMID:
29698690
6.

Whole genome sequencing of Caribbean Hispanic families with late-onset Alzheimer's disease.

Vardarajan BN, Barral S, Jaworski J, Beecham GW, Blue E, Tosto G, Reyes-Dumeyer D, Medrano M, Lantigua R, Naj A, Thornton T, DeStefano A, Martin E, Wang LS, Brown L, Bush W, van Duijn C, Goate A, Farrer L, Haines JL, Boerwinkle E, Schellenberg G, Wijsman E, Pericak-Vance MA, Mayeux R; Alzheimer's Disease Sequencing Project, Wang LS.

Ann Clin Transl Neurol. 2018 Mar 13;5(4):406-417. doi: 10.1002/acn3.537. eCollection 2018 Apr.

7.

Complement receptor 1 gene (CR1) intragenic duplication and risk of Alzheimer's disease.

Kucukkilic E, Brookes K, Barber I, Guetta-Baranes T; ARUK Consortium, Morgan K, Hollox EJ.

Hum Genet. 2018 Apr;137(4):305-314. doi: 10.1007/s00439-018-1883-2. Epub 2018 Apr 19.

8.

Molecular Mechanisms for Herpes Simplex Virus Type 1 Pathogenesis in Alzheimer's Disease.

Harris SA, Harris EA.

Front Aging Neurosci. 2018 Mar 6;10:48. doi: 10.3389/fnagi.2018.00048. eCollection 2018. Review.

9.

Updated Meta-Analysis of BIN1, CR1, MS4A6A, CLU, and ABCA7 Variants in Alzheimer's Disease.

Almeida JFF, Dos Santos LR, Trancozo M, de Paula F.

J Mol Neurosci. 2018 Mar;64(3):471-477. doi: 10.1007/s12031-018-1045-y. Epub 2018 Mar 4.

PMID:
29504051
11.

Recent studies on cellular and molecular mechanisms in Alzheimer's disease: focus on epigenetic factors and histone deacetylase.

Dubey H, Gulati K, Ray A.

Rev Neurosci. 2018 Mar 28;29(3):241-260. doi: 10.1515/revneuro-2017-0049.

PMID:
29397389
12.

Alzheimer risk loci and associated neuropathology in a population-based study (Vantaa 85+).

Mäkelä M, Kaivola K, Valori M, Paetau A, Polvikoski T, Singleton AB, Traynor BJ, Stone DJ, Peuralinna T, Tienari PJ, Tanskanen M, Myllykangas L.

Neurol Genet. 2018 Jan 18;4(1):e211. doi: 10.1212/NXG.0000000000000211. eCollection 2018 Feb.

13.

Association of complement receptor 1 gene polymorphisms with cognitive function.

Zijlstra LE, Jukema JW, Mooijaart SP, de Vries MA, Stott DJ, Castro Cabezas M, Trompet S.

Physiol Genomics. 2018 Feb 1;50(2):102-103. doi: 10.1152/physiolgenomics.00102.2017. Epub 2017 Dec 8.

14.

Genetic Biomarkers on Age-Related Cognitive Decline.

Lin CH, Lin E, Lane HY.

Front Psychiatry. 2017 Nov 21;8:247. doi: 10.3389/fpsyt.2017.00247. eCollection 2017. Review.

15.

Relative Impact of Complement Receptors CD21/35 (Cr2/1) on Scrapie Pathogenesis in Mice.

Kane SJ, Swanson E, Gordon EO, Rocha S, Bender HR, Donius LR, Aguzzi A, Hannan JP, Zabel MD.

mSphere. 2017 Nov 22;2(6). pii: e00493-17. doi: 10.1128/mSphereDirect.00493-17. eCollection 2017 Nov-Dec.

16.

Exome Sequencing of Extended Families with Alzheimer's Disease Identifies Novel Genes Implicated in Cell Immunity and Neuronal Function.

Cukier HN, Kunkle BK, Hamilton KL, Rolati S, Kohli MA, Whitehead PL, Jaworski J, Vance JM, Cuccaro ML, Carney RM, Gilbert JR, Farrer LA, Martin ER, Beecham GW, Haines JL, Pericak-Vance MA.

J Alzheimers Dis Parkinsonism. 2017 Aug;7(4). pii: 355. doi: 10.4172/2161-0460.1000355. Epub 2017 Jul 31.

17.

Alzheimer's Disease-Related Polymorphisms in Shunt-Responsive Idiopathic Normal Pressure Hydrocephalus.

Huovinen J, Helisalmi S, Paananen J, Laiterä T, Kojoukhova M, Sutela A, Vanninen R, Laitinen M, Rauramaa T, Koivisto AM, Remes AM, Soininen H, Kurki M, Haapasalo A, Jääskeläinen JE, Hiltunen M, Leinonen V.

J Alzheimers Dis. 2017;60(3):1077-1085. doi: 10.3233/JAD-170583.

PMID:
28984604
18.
19.

Functional annotation of Alzheimer's disease associated loci revealed by GWASs.

Han Z, Huang H, Gao Y, Huang Q.

PLoS One. 2017 Jun 26;12(6):e0179677. doi: 10.1371/journal.pone.0179677. eCollection 2017.

20.

Microglia limit the expansion of β-amyloid plaques in a mouse model of Alzheimer's disease.

Zhao R, Hu W, Tsai J, Li W, Gan WB.

Mol Neurodegener. 2017 Jun 12;12(1):47. doi: 10.1186/s13024-017-0188-6.

Supplemental Content

Loading ...
Support Center